This aligns with trial design: all major GLP-1 trials, including STEP-1 and SURMOUNT-1, required participants to follow a 500-calorie daily deficit and at least 150 minutes per week of moderate physical activity
Getting my prescriptions has always been smooth, and Ive never had a single issue
At Toxwell Med Spa & Wellness in Hallandale Beach, we pride ourselves on providing personalized, medically supervised care
Although the trial did not show a significant advantage in reducing cardiovascular events [6], or hospitalizations, it provided insights into liraglutides safety and tolerability in this patient population [6]
I think it would be helpful if there was some kind of acknowledgement that these are people that are living with a disease, and they've taken a treatment for that disease, and there is no shame in that they're improving their overall health. Evers said people need to move away from calling GLP-1 drugs weight-loss medications and instead call them obesity medications, which gives them an accurate medical context
The main cerebral target for THC is type-1 cannabinoid receptors (CB1R), which are widely expressed in the brain and regulate various functions including neurotransmitter release, neuro-astroglial communication, and cellular bioenergetic processes [29,30,31,32]